⌘K

Login Start Free

Home/Insiders/Fust Matthew

FM

SEC Insider//CIK 0001339226

Fust Matthew

CIK 00013392261 companySOUTH SAN FRANCISCO, CA

Transactions

11

Companies

1

Filings

11

CIK

0001339226

Recent Transactions

11 trades

Award
Viracta Therapeutics, Inc.$VIRX
Stock Option (Right to Buy)
2016-06-30+50,000→ 50,000 total
Award
Viracta Therapeutics, Inc.$VIRX
Stock Option (Right to Buy)
2015-06-30+40,000→ 40,000 total
Award
Viracta Therapeutics, Inc.$VIRX
Stock Option (Right to Buy)
2014-06-30+20,000→ 20,000 total
Award
Viracta Therapeutics, Inc.$VIRX
Stock Option (Right to Buy)
2013-06-28+20,000→ 20,000 total
Award
Viracta Therapeutics, Inc.$VIRX
Stock Option (Right to Buy)
2012-06-29+25,000→ 25,000 total
Award
Viracta Therapeutics, Inc.$VIRX
Stock Option (Right to Buy)
2011-06-30+50,000→ 50,000 total
Award
Viracta Therapeutics, Inc.$VIRX
Stock Option (Right to Buy)
2010-06-02+10,000→ 10,000 total
Award
Viracta Therapeutics, Inc.$VIRX
Stock Option (Right to Buy)
2009-07-31+90,000→ 90,000 total
Award
Viracta Therapeutics, Inc.$VIRX
Stock Option (Right to Buy)
2009-06-18+10,000→ 10,000 total
Award
Viracta Therapeutics, Inc.$VIRX
Non-Qualified Stock Option (right to buy)
2007-06-05+10,000→ 10,000 total
Award
Viracta Therapeutics, Inc.$VIRX
Employee Stock Option (right to buy)
2006-06-19+10,000→ 10,000 total

Companies

1

Viracta Therapeutics, Inc.
Director
$VIRX

Recent Filings

11

Address

C/O SUNESIS PHARMACEUTICALS, INC. 395 OYSTER POINT BLVD., SUITE 400

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov